Cronos Group Inc. (NASDAQ: CRON) reported fourth quarter 2020 earnings results today.
Net revenue more than doubled year-over-year to $17 million, driven by growth in the adult-use market in Canada, sales in the Israeli medical market as well as growth in the US segment.
The company incurred a comprehensive loss of $61 million, or $0.31 per share, compared to an income of $89.8 million, or $0.17 per share, last year.
Cash and short-term investments totaled approx. $1.3 billion at the end of the period.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
